BlackRock’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.6B | Sell |
119,010,973
-4,184,605
| -3% | -$586M | 0.29% | 54 |
|
|
2025
Q4 | $15.1B | Buy |
123,195,578
+6,914,187
| +6% | +$840M | 0.26% | 61 |
|
|
2025
Q3 | $12.9B | Buy |
116,281,391
+1,401,469
| +1% | +$159M | 0.23% | 73 |
|
|
2025
Q2 | $12.7B | Sell |
114,879,922
-1,224,650
| -1% | -$130M | 0.24% | 66 |
|
|
2025
Q1 | $13B | Sell |
116,104,572
-4,251,269
| -4% | -$439M | 0.27% | 59 |
|
|
2024
Q4 | $11.1B | Sell |
120,355,841
-1,579,953
| -1% | -$142M | 0.23% | 71 |
|
|
2024
Q3 | $10.2B | Buy |
121,935,794
+1,303,771
| +1% | +$99.5M | 0.21% | 74 |
|
|
2024
Q2 | $8.28B | Sell |
120,632,023
-1,899,004
| -2% | -$127M | 0.19% | 90 |
|
|
2024
Q1 | $8.98B | Sell |
122,531,027
-261,984
| -0.2% | -$20.1M | 0.21% | 80 |
|
|
2023
Q4 | $9.95B | Sell |
122,793,011
-3,422,449
| -3% | -$266M | 0.25% | 59 |
|
|
2023
Q3 | $9.46B | Buy |
126,215,460
+21,281
| +0% | +$1.64M | 0.27% | 57 |
|
|
2023
Q2 | $9.73B | Sell |
126,194,179
-362,347
| -0.3% | -$28.9M | 0.27% | 64 |
|
|
2023
Q1 | $10.5B | Sell |
126,556,526
-5,003,724
| -4% | -$414M | 0.31% | 54 |
|
|
2022
Q4 | $11.3B | Buy |
131,560,250
+3,099,517
| +2% | +$245M | 0.35% | 45 |
|
|
2022
Q3 | $7.92B | Buy |
128,460,733
+1,523,122
| +1% | +$96M | 0.27% | 62 |
|
|
2022
Q2 | $7.85B | Buy |
126,937,611
+5,228,246
| +4% | +$324M | 0.25% | 68 |
|
|
2022
Q1 | $7.24B | Buy |
121,709,365
+2,748,159
| +2% | +$176M | 0.19% | 87 |
|
|
2021
Q4 | $8.64B | Sell |
118,961,206
-2,021,143
| -2% | -$139M | 0.22% | 79 |
|
|
2021
Q3 | $8.45B | Sell |
120,982,349
-2,822,189
| -2% | -$198M | 0.24% | 75 |
|
|
2021
Q2 | $8.53B | Sell |
123,804,538
-918,595
| -0.7% | -$61.3M | 0.24% | 72 |
|
|
2021
Q1 | $8.06B | Buy |
124,723,133
+13,539,799
| +12% | +$873M | 0.24% | 71 |
|
|
2020
Q4 | $6.48B | Sell |
111,183,334
-6,600,470
| -6% | -$398M | 0.21% | 83 |
|
|
2020
Q3 | $7.44B | Buy |
117,783,804
+1,949,534
| +2% | +$135M | 0.27% | 60 |
|
|
2020
Q2 | $8.91B | Buy |
115,834,270
+14,619,279
| +14% | +$1.12B | 0.36% | 50 |
|
|
2020
Q1 | $7.57B | Sell |
101,214,991
-5,258,603
| -5% | -$363M | 0.37% | 48 |
|
|
2019
Q4 | $6.92B | Buy |
106,473,594
+6,469,308
| +6% | +$421M | 0.27% | 68 |
|
|
2019
Q3 | $6.34B | Buy |
100,004,286
+146,935
| +0.1% | +$9.61M | 0.27% | 66 |
|
|
2019
Q2 | $6.75B | Sell |
99,857,351
-2,705,872
| -3% | -$178M | 0.29% | 61 |
|
|
2019
Q1 | $6.67B | Sell |
102,563,223
-1,622,854
| -2% | -$108M | 0.3% | 61 |
|
|
2018
Q4 | $6.52B | Buy |
104,186,077
+2,195,948
| +2% | +$153M | 0.33% | 51 |
|
|
2018
Q3 | $7.87B | Sell |
101,990,129
-3,240,531
| -3% | -$245M | 0.34% | 47 |
|
|
2018
Q2 | $7.45B | Sell |
105,230,660
-5,393
| -0% | -$381K | 0.34% | 46 |
|
|
2018
Q1 | $7.93B | Buy |
105,236,053
+1,438,806
| +1% | +$114M | 0.38% | 43 |
|
|
2017
Q4 | $7.44B | Buy |
103,797,247
+1,552,359
| +2% | +$118M | 0.35% | 45 |
|
|
2017
Q3 | $8.28B | Sell |
102,244,888
-2,661,606
| -3% | -$204M | 0.42% | 42 |
|
|
2017
Q2 | $7.43B | Buy |
104,906,494
+1,937,031
| +2% | +$129M | 0.39% | 41 |
|
|
2017
Q1 | $6.99B | Buy |
102,969,463
+99,405,266
| +2,789% | +$6.99B | 0.38% | 38 |
|
|
2016
Q4 | $255M | Sell |
3,564,197
-9,227
| -0.3% | -$686K | 0.36% | 45 |
|
|
2016
Q3 | $283M | Buy |
3,573,424
+205,128
| +6% | +$16.7M | 0.41% | 47 |
|
|
2016
Q2 | $281M | Sell |
3,368,296
-18,024
| -0.5% | -$1.6M | 0.42% | 46 |
|
|
2016
Q1 | $311M | Sell |
3,386,320
-1,122,431
| -25% | -$101M | 0.5% | 36 |
|
|
2015
Q4 | $456M | Buy |
4,508,751
+113,844
| +3% | +$11.8M | 0.67% | 24 |
|
|
2015
Q3 | $432M | Buy |
4,394,907
+291,477
| +7% | +$32.4M | 0.68% | 27 |
|
|
2015
Q2 | $480M | Sell |
4,103,430
-282,746
| -6% | -$30.9M | 0.71% | 21 |
|
|
2015
Q1 | $430M | Buy |
4,386,176
+97,582
| +2% | +$9.91M | 0.59% | 28 |
|
|
2014
Q4 | $404M | Buy |
4,288,594
+23,827
| +0.6% | +$2.46M | 0.58% | 34 |
|
|
2014
Q3 | $454M | Buy |
4,264,767
+160,269
| +4% | +$15.7M | 0.66% | 24 |
|
|
2014
Q2 | $340M | Sell |
4,104,498
-18,275
| -0.4% | -$1.42M | 0.51% | 37 |
|
|
2014
Q1 | $292M | Sell |
4,122,773
-550,034
| -12% | -$43.1M | 0.47% | 44 |
|
|
2013
Q4 | $351M | Buy |
4,672,807
+1,138,804
| +32% | +$79.3M | 0.57% | 34 |
|
|
2013
Q3 | $222M | Sell |
3,534,003
-97,328
| -3% | -$5.82M | 0.42% | 50 |
|
|
2013
Q2 | $186M | Buy |
+3,631,331
| New | +$189M | 0.37% | 56 |
|
Other funds holding GILD
VCM
VPM
BlackRock's GILD Position: Q1 2026 in Review
BlackRock reduced its Gilead Sciences (GILD) stake by 3.4% in Q1 2026, selling an estimated $586M and leaving 119,010,973 shares worth $16.6B. The position accounts for 0.29% of the portfolio, ranked #54.
BlackRock first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- BlackRock held 119,010,973 shares of Gilead Sciences worth $16.6B as of Q1 2026.
- BlackRock sold 4,184,605 Gilead Sciences shares in Q1 2026, an estimated $586M.
- Gilead Sciences made up 0.29% of BlackRock's portfolio in Q1 2026, its #54 holding.
- BlackRock first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.